The H.E.L.P.™ System provided in the U.S. by B. Braun Medical is a proven procedure, known as LDL Apheresis, which selectively removes LDL cholesterol from the patient's bloodstream while leaving other blood components intact. Once the patient's blood is removed from a vein in the arm, the plasma is separated from the rest of the blood using a membrane plasma filter. The plasma meets the heparin buffer solution at which time a reaction occurs, allowing the LDL-cholesterol to be filtered. The LDL-reduced plasma then flows through a series of three other filters removing excess heparin and fluids. The LDL depleted plasma is then combined with the patient's blood and returned to the patient.
B. Braun's Plasmat®-secura is an automated machine with built-in safety features, including air detectors and various alarms, that monitors and controls the LDL Apheresis procedure from start to finish. Since 1987 over 100,000 treatments have been performed worldwide on the H.E.L.P.™ System. The clinical benefits of the H.E.L.P.™ System have been documented in numerous published reports in the U.S. and in Europe. We invite you to review our H.E.L.P.™ System brochure, "An Introduction to the H.E.L.P.™ (Heparin-induced Extracorporeal Lipoprotein Precipitation) System for Patients with Treatment Refractory Hypercholesterolemia" which will provide you with a detailed explanation of LDL-Apheresis and the H.E.L.P.™ System procedure.

For more information on the H.E.L.P.™ System, call 1-800-848-2066,
or email us at rtd@bbmus.com.